Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Ventyx Biosciences Inc VTYX

Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops oral therapies for patients with autoimmune, inflammatory, and neurodegenerative diseases. The company’s lead clinical product candidate is VTX958, a selective allosteric tyrosine kinase type 2 inhibitor for Crohn’s disease. It is also developing Tamuzimod, a sphingosine 1 phosphate receptor modulator that is in... see more

Current News (NDAQ:VTYX)

Halper Sadeh LLC Encourages VTYX and SNCY Shareholders to Contact the Firm to Discuss Their Rights

GlobeNewswire 2 days ago

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Nathan's Famous, Inc. (Nasdaq - NATH), Lisata Therapeutics, Inc. (Nasdaq - LSTA), Sun Country Airlines Holdings, Inc. (Nasdaq - SNCY), Ventyx Biosciences, Inc. (Nasdaq - VTYX)

GlobeNewswire 2 days ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ventyx Biosciences, Inc. - VTYX

ACCESS Newswire 5 days ago

Halper Sadeh LLC Encourages ONTF, VTYX, SNCY Shareholders to Contact the Firm to Discuss Their Rights

GlobeNewswire 6 days ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ventyx Biosciences, Inc. - VTYX

ACCESS Newswire 6 days ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ventyx Biosciences, Inc. - VTYX

ACCESS Newswire 7 days ago

Halper Sadeh LLC Encourages VTYX, PEN, CWAN Shareholders to Contact the Firm to Discuss Their Rights

GlobeNewswire 8 days ago

$HAREHOLDER ALERT: The M&A Class Action Reminds $hareholders of Upcoming Merger Deadlines-FFIC, OCFC, VTYX, and ONTF

GlobeNewswire 8 days ago

Halper Sadeh LLC Encourages VTYX, ONTF, FFIC, OCFC Shareholders to Contact the Firm to Discuss Their Rights

GlobeNewswire 9 days ago

Opinion & Analysis (NDAQ:VTYX)

No current opinion is available.

Bullboard Posts (NDAQ:VTYX)

Buy buddy buy.

Otherwise it will be FOMO time for you fellas out there today anyway
coolfooldumbguy - October 23, 2025

Ventyx Biosciences, Inc. (VTYX): A Promising Pipeline of Nov

http://beyondspx.com/2024/08/01/ventyx-biosciences-inc-vtyx-a-promising-pipeline-of-novel-therapies-targeting-inflammatory-diseases/
MikeTester - August 2, 2024